Followers | 24 |
Posts | 4,556 |
Boards Moderated | 0 |
Alias Born | 10/29/2019 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CEO Michael Handley will take us big places. $STAB
“Submitting this study protocol to the FDA is a critical milestone in the development of our COVID-19 program,” said Michael K. Handley, President and Chief Executive Officer, Statera Biopharma. “As the world continues to struggle with the COVID-19 pandemic, post-acute COVID syndrome remains a widespread, often debilitating condition that is not well understood. With STAT-205 Statera looks to potentially offer a promising treatment approach to those patients facing the long-lasting burden of the illness.”
it's been a painful process. but we will received of updates soon, but further updates as to the ELD cert would be extremely helpful. $MJLB
Dr Chandran is a genius. Can't believe how undervalued still. All the DD is right there https://finance.yahoo.com/news/statera-biopharma-announces-changes-board-123200501.html $STAB
Well said and a very positive indicator that we are sitting on a GOLD MINE Here. $MJLB
Pet wearable device is a very good strategy for creating potential another stream of revenues.$MJLB .
I'm still here and kicking! I've been waiting the updates about expansion, finalizing every last detail for $MJLB's ELD, and Should prove to be a fruitful on the way to Summer imo.
STAT-201 in the treatment of pediatric Crohn's Disease will revolutionalize the biotech Industry $STAB
This is a sleeping monster brother. Glad I added more cheapies yesterday. $STAB
Trucking/blockchain is the future and adding a usa address is a plus.. i hope this thing gets moving some time this summer. $MJLB
$STAB acquired ImQuest BioSciences is a real deal! This, in turn, will allow the company to develop a competitive advantage over other players in the biotech industry.
Buckle up folks. Its coming!
$BTDG
i bet summer 2022 we will be in shock and awe with biggest run in companies history if my hunch is correct $BTDG
Company coming to METAVERSE here big future on the way folks. They have yet to announce their MEGA SURPRISES imo! $SFLM
SFLM is way undervalued at these levels. #metaverse & #NFT market are HUGE.
Dang! you are totally right!
100K shares could be traded before close
$STAB
This stock is soo undervalued. Should be trading $1++ MINIMUM!!! $STAB
added Dr. Chandran is a GAME CHANGER here
$STAB
100% AGREE shares are going to get more scarce with each passing day. Folks better lock and hold tight for the big run coming! $STAB
The numerous steps to further the development of $stab clinical-stage pipeline that has well-positioned to achieve numerous milestones in 2022 https://www.marketscreener.com/quote/stock/CYTOCOM-INC-125324701/news/TopNewsGuide-STAB-Well-Positioned-For-2022-Growth-Phase-3-Update-39607365/
This company keeps growing!
Topline Projections for the 3 Months Ending March 31, 2022, based on year-to-date performance
** Total Revenues of ~$1.1 million, up 142% year over year
** Live Event Segment revenues of ~$310k, up 62% year over year, broken down into Gate ticket sales of ~$250k and Pay Per View sales of ~$60k
** B2 Training Facilities segment revenues of ~$700k, up 165% year over year, broken down into ONE MORE Gym revenues of ~$360k and Spartan Fitness revenues of ~$340k
$BTDG
new tweet here: https://twitter.com/b2digitalotc/status/1498281342404079618
$BTDG
In a Phase 2 study, STAT-201 demonstrated safety as well as remission in 67% of participants and 43% mucosal healing as measured by endoscopic assessment. No serious adverse events were reported in the trial. STAT-201 has received FDA orphan drug designation for treatment of CD in pediatric patients. $STAB
Power hour approaching
$STAB
Holding steady here. This looks like the new support level $STAB
Cheap biotech is a diamond in the rough.
$STAB
Time to roll lets go!
$STAB
Cool thing here is they on a Phase 3 clinical trial for STAT-201 in the treatment of pediatric Crohn’s Disease (CD), a chronic relapsing inflammatory condition of the gastrointestinal tract. $STAB
New tweet:
We are proud to announce further evolution our Board of Directors. Satish Chandran, joined the Board effective Feb. 24. Steve Barbarick has taken on an advisory position after serving as a Director. To learn more, visit: https://bit.ly/3t71zzF
We are proud to announce further evolution our Board of Directors. Satish Chandran, joined the Board effective Feb. 24. Steve Barbarick has taken on an advisory position after serving as a Director. To learn more, visit: https://t.co/ipafxcWcds pic.twitter.com/QhQe9cKIj8
— Statera Biopharma Inc (@StateraBio) February 25, 2022
Last year $PSWW acquired eTruck, do you people do any DD before buying into this company?
https://www.globenewswire.com/news-release/2021/09/23/2302272/0/en/Principal-Provides-Status-Update-of-eTruck-Transportation-s-Class-6-EV-Conversion-Technology.html
oil + renewable energy + EV is going to be hot this year. $PSWW
CEO about to shock everyone sooner than later. I guess many dont know the meaning of PATIENCE! $PSWW
The CEO of Principal Solar is a real deal
pswwenergy.com/management-team/
I hope people get ready to load Friday cheapies here. Better days up ahead imho. $BTDG
This company is on the winning track in 2022.
$BTDG
Let more catalysts hit and then you’ll know what a beast of a company this is. $BTDG
Intermezzo: The current president of Ukraine is an actor, and the mayor of Kyiv is a former MMA fighter. $BTDG
extremely undervalued EV stocks $PSWW = generational wealth!
Appreciate the update from the company $PSWW this is the year of EV
$PSWW Principal Solar Announces Successful Completion of Regulation A Plus Equity Offering
https://www.globenewswire.com/news-release/2022/02/24/2391390/0/en/Principal-Solar-Announces-Successful-Completion-of-Regulation-A-Plus-Equity-Offering.html
DALLAS, TEXAS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Principal Solar, Inc. (OTC Pink: PSWW) (“Principal” or “the Company”), a strategic investor in organizations and technologies that support next-generation opportunities in traditional, renewable, and clean energy sectors as well as an investor in undervalued petroleum-producing properties, today announced the successful, final closing of its Regulation A Plus equity offering (SEC File No. 025-11253) (the “Offering”). The Offering, which commenced on November 25, 2020, and concluded on February 16, 2022, raised gross proceeds of US$8.65 million* through the sale of 96.6 million shares* of the Company’s common stock at US$0.0895 per share.
“We view the success of our Regulation A Plus Offering as further validation of Principal’s business model and proof positive that investors see real upside potential in funding practical, near-term solutions to today’s transitional energy challenges,” said K. Bryce “Rick” Toussaint, CPA, MBA, Principal’s Chairman and CEO. “On a personal note, I’d like to extend a warm welcome to the new Principal stakeholders that participated in the Offering. We have big plans for the Company’s future, and I’m glad you’ve taken the opportunity to join us.”
The proceeds of the Offering have been used to pay down outstanding debt and expensive convertible notes as well as to invest in or acquire oil and gas leases, oil and gas extraction technologies, operating companies with existing revenues, and electric vehicle technologies.
*Numbers shown are approximate. Complete details are included in the Form 1-Z Exit Report filed with the Securities and Exchange Commission, which may be viewed here: https://www.sec.gov/Archives/edgar/data/0001587476/000168316822001059/xsl1-Z_X01/primary_doc.xml
$PSWW seems to be quite committed to the highest levels of transparency, integrity, solvency, and accountability
“We view the success of our Regulation A Plus Offering as further validation of Principal’s business model and proof positive that investors see real upside potential in funding practical, near-term solutions to today’s transitional energy challenges,” said K. Bryce “Rick” Toussaint, CPA, MBA, Principal’s Chairman and CEO. “On a personal note, I’d like to extend a warm welcome to the new Principal stakeholders that participated in the Offering. We have big plans for the Company’s future, and I’m glad you’ve taken the opportunity to join us.”$PSWW
https://finance.yahoo.com/news/principal-solar-announces-successful-completion-130000312.html
Massive revs coming in $PSWW going to be a monster and REG A closed let's go!
Doing some DD here ..thanks
Quote:
$PSWW: Added another 300k today
Deep value here at 0.0147
GO $PSWW
This is going to be our best ever year in OTC history! Folks should check out the latest PR $MJLB
Ultrack CEO Michael Marsbergen enthusiastically explained the acquisition: "This important 100% acquisition of a seasoned USA trucking company immediately adds value to Ultrack's bottom line while expanding our corporate reach into likeminded horizontal markets. I believe the MOU expresses favorable terms to both companies and provides tremendous benefits for both companies to come together as one under the Ultrack umbrella. Furthermore, this acquisition immediately expands Ultrack's footprint into strategic USA locations so that Ultrack can be thought of more as a 'North American' company and not simply a 'Canadian' company."
This is the reason why i've held and will continue to hold through certification because we are going to kaboom imo $MJLB
STAT-201 is truly revolutionary after the FDA granted STAT-201 Orphan Drug Designation for the treatment of Crohn’s Disease in pediatric patients, STAB intends to initiate its Phase 3 clinical trials in the coming months. Given that Crohn’s disease affects an estimated 3 million US adults on an annual basis, the upside potential for this drug is looking promising. $STAB